Brief: Cytrx reports loss per share of $0.27 for Q2 2016
29/07/2016 14:00
July 29 (Reuters) - Cytrx Corp CYTR.O
* Q2 loss per share $0.27
Source text for Eikon: ID:nPndbZPXa
Further company coverage: CYTR.O
((Bengaluru Newsroom; +91 80 6749 1130;))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C